mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.001 |
1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00094 |
1 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.00091 |
1 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.0009 |
1 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
0.0012 |
1 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.00091 |
1 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |